IFM Certified Practitioner (Institute for Functional Medicine, USA)

Dr. Goodenowe Certified Practitioner (Prodrome Science, USA)

ReCODE 2.0 Certified Practitioner (Apollo Health, USA)

Functional Medicine Organic Acids Mentorship (The Kalish Institute for Functional Medicine, USA)

Lab Interpretation Bootcamp - Functional Genomics (The Kalish Institute for Functional Medicine, USA)

Member of the Institute for Functional Medicine (IFM, USA)

Member of the International Lyme and Associated Diseases Society (ILADS, USA)

Member of the International Society for Environmentally Acquired Illness (ISEAI, USA)

Fellow of the American Academy of Ozonotherapy (FAAO, USA)

Certified in Ozonotherapy (Dr. Frank Shallenberger, USA)

Mentee des Mold and Mycotoxin Mentorship Program Dr. Neil Nathan and Dr. Jill Crista (USA)

Certified Mold-Literate Practitioner (Dr. Jill Crista, USA)

Completed the PANDAS & PANS: An Integrative Approach Course (Dr. Jill Crista, USA)

Participant of The Fundamentals of Lyme and Tick-Borne Diseases (ILADS, USA)

Completed the ILADEF Physician Training Program (ILADS, USA)

HeartMath® Certified Practitioner (HeartMath® Institute, USA)

Certified Virtual Coach (Eben Pagan Training, USA)

Certified Goal Success Life Coach (Transformation Academy, USA)

Certified Toxicity and Detox Specialist (Health Center of the Future, USA)

Fachärztin für Augenheilkunde

FEBO (Fellow of the European Board of Ophthalmology)

Recipient of the International Scholar Award der American Academy of Ophthalmology 2018

Oberfeldarzt der Reserve (Bundeswehr)

Forschungsaufenthalt im Rahmen der Dissertation bei Prof. Judah Folkman, Vascular Biology Program (Childrens Hospital Boston, Harvard Medical School, USA)

Dissertation:

“Einfluß von Apolipoprotein H auf die Endothelmodifikation und Endothelaktivität”, Johann Wolfgang Goethe-Universität (Frankfurt am Main)

Publikationen:

Beecken WD, Ringel EM, Babica J, Oppermann E, Jonas D, Blaheta RA. Plasmin-clipped beta(2)-glycoprotein-I inhibits endothelial cell growth by down-regulating cyclin A, B and D1 and up-regulating p21 and p27. Cancer Lett. 2010 Oct 28;296(2):160-7. doi: 10.1016/j.canlet.2010.04.010. PMID: 20435405.

Beecken WD, Engl T, Ringel EM, Camphausen K, Michaelis M, Jonas D, Folkman J, Shing Y, Blaheta RA. An endogenous inhibitor of angiogenesis derived from a transitional cell carcinoma: clipped beta2-glycoprotein-I. Ann Surg Oncol. 2006 Sep;13(9):1241-51. doi: 10.1245/s10434-006-9009-9. Epub 2006 Sep 7. PMID: 16955386.

Engl T, Relja B, Marian D, Blumenberg C, Müller I, Beecken WD, Jones J, Ringel EM, Bereiter-Hahn J, Jonas D, Blaheta RA. CXCR4 chemokine receptor mediates prostate tumor cell adhesion through alpha5 and beta3 integrins. Neoplasia. 2006 Apr;8(4):290-301. doi: 10.1593/neo.05694. PMID: 16756721; PMCID: PMC1600676.

Engl T, Relja B, Blumenberg C, Müller I, Ringel EM, Beecken WD, Jonas D, Blaheta RA. Prostate tumor CXC-chemokine profile correlates with cell adhesion to endothelium and extracellular matrix. Life Sci. 2006 Mar 13;78(16):1784-93. doi: 10.1016/j.lfs.2005.08.019. Epub 2005 Nov 2. PMID: 16263140.